Karas Eric bought SPRY
June 18, 2025 · Form 4 insider transaction
Karas Eric bought 15,000 shares of ARS Pharmaceuticals, Inc. at $1.50 per share, a transaction worth $22.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$1.50
Total value
$22.5K
InsiderKaras Eric
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 18, 2025
Filing dateJune 20, 2025
Shares owned after22,696
OwnershipDirect
10b5-1 planNo
AmendedNo